Neugut A I, Marvin M R, Rella V A, Chabot J A
Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Oncology (Williston Park). 1997 Apr;11(4):529-36; discussion 545, 549-50.
Even though the small intestine contains 90% of the gastrointestinal tract mucosa and is located between the stomach and large intestine, two organs with a high cancer incidence, adenocarcinoma of the small intestine is 1/50th as common as adenocarcinoma of the large bowel. In several other respects, small-intestinal adenocarcinoma resembles large bowel adenocarcinoma; eg, it arises from adenomatous polyps, co-occurs in the same individuals, and has a similar pattern of incidence rates by country. Small-intestinal adenocarcinoma is diagnosed prior to surgery in only about 50% of cases and often occurs in conjunction with small bowel obstruction. The mainstay of treatment is surgery; prognosis depends on stage at presentation. Little is known about the use of radiotherapy and chemotherapy in this malignancy, but most physicians utilize therapeutic strategies modeled on the management of large-intestinal adenocarcinoma. Clarification of the reason for the low incidence of small-intestinal adenocarcinoma could lead to new interventions for the prevention of colorectal cancer.
尽管小肠包含90%的胃肠道黏膜,且位于胃癌和大肠癌这两种癌症发病率较高的器官之间,但小肠腺癌的发病率仅为大肠癌的1/50。在其他几个方面,小肠腺癌与大肠癌相似;例如,它起源于腺瘤性息肉,在相同个体中同时发生,并且在不同国家具有相似的发病率模式。小肠腺癌仅在约50%的病例中在手术前被诊断出来,并且常与小肠梗阻同时发生。治疗的主要方法是手术;预后取决于就诊时的分期。对于这种恶性肿瘤中放疗和化疗的使用了解甚少,但大多数医生采用以大肠癌治疗为蓝本的治疗策略。阐明小肠腺癌发病率低的原因可能会带来预防结直肠癌的新干预措施。